To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Novartis dashes private equity hopes with public Sandoz spin-off; Exits getting tricky for funds
LDC announced its exit from Littlefish, which is the firm's fifth exit in the last 12 months.
